Chondroplasty Surgery: How Joint Cartilage Repair Works

Chondroplasty is a surgical procedure that smooths or trims damaged cartilage inside a joint, most often the knee. It is performed arthroscopically through small incisions and is one of the most common cartilage procedures worldwide, though its role has narrowed in recent years as restorative techniques have gained ground. The procedure works well for certain patients with focal cartilage injuries but remains controversial when applied broadly to osteoarthritis, where major clinical guidelines now recommend against it.

What Happens During the Procedure

During chondroplasty, a surgeon inserts a small camera and instruments through two or three tiny incisions around the joint. The goal is to remove loose flaps, unstable fragments, and rough edges from damaged cartilage so that the remaining surface is smoother and less likely to catch or irritate surrounding tissue. The surgeon does not attempt to regrow cartilage or fill the defect. Instead, the idea is palliative: clean up what is there so the joint moves with less friction and pain.

There are two main ways to do this. The traditional approach uses a motorized shaver, essentially a tiny rotating blade that trims cartilage mechanically. The newer approach uses a radiofrequency (RF) probe, which delivers controlled thermal energy to melt and smooth the surface rather than cutting it. The distinction matters more than you might expect.

Mechanical Shaver Versus Radiofrequency

Head-to-head comparisons between mechanical debridement and radiofrequency chondroplasty consistently favor the RF approach on most clinical measures. In a lab study comparing the two techniques on damaged cartilage specimens, the RF probe achieved acceptable smoothing in 90% of samples versus 49% for the mechanical shaver, while also removing less total tissue depth per pass.¹ In other words, the RF probe left a smoother surface while being gentler on the cartilage underneath.

Clinical trials have backed this up. A randomized controlled trial of patients undergoing chondroplasty alongside partial meniscectomy found that those treated with RF returned to activity about five days sooner and reported significantly lower pain scores at every time point through one year. Their functional knee scores were also substantially better at the one-year mark, and far fewer RF patients were still using anti-inflammatory medications for knee pain (roughly 2% versus 23%).²

The advantages held up over time. At four years, the revision rate in the mechanical shaver group was dramatically higher, and patients who avoided revision still scored meaningfully better on knee function questionnaires if they had received RF treatment.³ At the ten-year mark of the same cohort, 60% of the mechanical shaver group had undergone revision surgery compared with about 23% of the RF group. Joint space also narrowed more rapidly in the mechanical group, suggesting faster progression of arthritis.⁴

There is one important caveat. An animal study found that radiofrequency energy caused more cell death in the cartilage layer than mechanical debridement, and the treated cartilage looked worse histologically compared with untreated controls.⁵ This has raised concerns about thermal damage to surrounding healthy cartilage, particularly when the probe lingers too long or the temperature is too high. A prospective clinical series specifically investigated whether RF chondroplasty causes bone death (osteonecrosis) beneath the treated area and found it in only 2 out of 50 patients, concluding the risk is low when proper technique is used.⁶ The takeaway is that RF chondroplasty seems to produce better clinical results than mechanical shaving, but the surgeon needs to be careful with temperature control and dwell time.

Outcome Scores and What They Mean for You

If you’re reading about chondroplasty outcomes, you’ll run into a blizzard of acronyms: Lysholm, KOOS, IKDC, Tegner. These are standardized questionnaires that measure things like pain, knee function, ability to do daily activities, sports participation, and quality of life. Higher numbers are better. A systematic review of RF chondroplasty in the knee reported that average postoperative scores ranged from good to excellent across studies, with Lysholm scores between 83 and 91 in lesions spanning mild to severe damage.⁷ A Lysholm score above 84 is generally considered “good,” so most patients fell into that category or above.

A large long-term study of patients with arthroscopically verified focal cartilage lesions found that those who did not go on to need a joint replacement or realignment procedure had significantly better pain and function scores at final follow-up than they did before surgery.⁸ That sounds encouraging, but it’s also an important selection effect: the patients who did well are by definition the ones who didn’t need further surgery. The real question is how many people eventually do need more.

The Long Road to Joint Replacement

Chondroplasty does not fix the underlying problem. It smooths damaged cartilage, but the cartilage does not heal or regenerate, and the conditions that caused the damage in the first place, whether injury, alignment issues, or degenerative wear, are still present. So for many patients, chondroplasty is a chapter in a longer story that may eventually end with a knee replacement.

A Norwegian study following patients for about 20 years after they were diagnosed with a focal cartilage lesion found that roughly one in five underwent knee replacement during that period. Body weight was the strongest risk factor: being overweight nearly quadrupled the risk, and being obese increased it nearly sixfold. The severity of the cartilage damage also mattered, with higher-grade lesions roughly tripling the risk.⁹

A large English database study found that among patients over 30 who had undergone chondroplasty, about 6% received a knee replacement within one year and about 14% within five years. That group was over 17 times more likely to undergo replacement than the general population without a history of chondroplasty.¹⁰ Among patients over 50 specifically, conversion rates to total knee replacement were around 10% at one year and nearly 16% at three years.¹¹

These numbers do not mean chondroplasty caused the need for replacement. Patients who get chondroplasty already have damaged joints, and many would have progressed to replacement regardless. But the data does make clear that chondroplasty is not a long-term fix for most people with significant cartilage wear. It buys time, reduces symptoms, and for younger patients with isolated injuries, that time can be substantial. For older patients with widespread degeneration, the runway tends to be shorter.

The Osteoarthritis Controversy

This is where chondroplasty’s story gets uncomfortable. For decades, arthroscopic debridement and chondroplasty were standard practice for knee osteoarthritis, the degenerative, widespread cartilage loss that affects millions of people. Several landmark trials in the 2000s and 2010s showed that arthroscopic surgery for osteoarthritis was no better than sham surgery or physical therapy alone, and the medical community shifted its position. A systematic review of clinical practice guidelines for hip and knee osteoarthritis found that higher-quality guidelines consistently recommended against arthroscopy for this purpose.¹²

This distinction is critical for patients. If your cartilage damage is a focal lesion, meaning a specific area of damage surrounded by relatively healthy cartilage, chondroplasty may genuinely help. If your cartilage damage is diffuse osteoarthritis, with widespread thinning across the joint surface, the evidence suggests chondroplasty provides no meaningful benefit beyond what you would get from physical therapy and pain management alone. Unfortunately, the difference between these two situations is not always obvious on an MRI, and the line between “focal lesion with some surrounding degeneration” and “early osteoarthritis” can be blurry.

Usage patterns reflect this shifting understanding. An analysis of surgical data from 2007 to 2016 found that palliative procedures like chondroplasty had been declining, with the ratio of chondroplasty to restorative procedures dropping significantly each year. By 2013, microfracture had overtaken chondroplasty as the most commonly performed cartilage procedure.¹³

When Cartilage Damage Shows Up During Another Procedure

One of the most common scenarios is unexpected: a surgeon goes in to repair a torn meniscus or remove loose fragments and discovers cartilage damage they weren’t expecting. The natural instinct is to clean it up while you’re in there. But a randomized controlled trial specifically tested this and found that debriding unstable cartilage flaps encountered during partial meniscectomy made no difference to patient outcomes at one year compared with leaving them alone.¹⁴ The study recommended leaving incidentally discovered lesions in place.

This finding challenges a lot of routine surgical practice. Many surgeons still tidy up loose cartilage whenever they see it, partly out of habit and partly because it seems intuitively wrong to leave flapping tissue inside a joint. But the evidence suggests that for unstable flaps found during meniscus surgery, a “leave it alone” approach produces equivalent results.

Chondroplasty Beyond the Knee

The knee gets the most attention, but chondroplasty is performed in other joints too. In the hip, it’s often part of a larger arthroscopic procedure for femoroacetabular impingement, a condition where abnormal bone shape causes the hip socket and thigh bone to grind against each other. A systematic review of arthroscopic femoral osteochondroplasty, the reshaping of bone and cartilage in the hip, found a large overall effect size across studies, with patients improving by an average of 24 points on the non-arthritic hip score.¹⁵ However, the presence of high-grade cartilage damage in the hip predicted worse outcomes overall, and among those patients, there was no significant difference between chondroplasty and microfracture at two years.¹⁶

In the ankle, chondroplasty is used for osteochondral lesions of the talus, which are areas of damaged cartilage and underlying bone that typically result from ankle sprains or fractures. A randomized controlled trial comparing chondroplasty, microfracture, and osteochondral autograft transplantation (taking a cartilage plug from elsewhere and transplanting it) found no significant differences in functional outcomes at two years. Chondroplasty and microfracture did have an advantage in early postoperative pain.¹⁷ A broader systematic review of treatment strategies for talar lesions found that bone marrow stimulation techniques, microfracture and similar procedures that stimulate the body’s own repair, remain the preferred first-line approach for primary lesions due to their effectiveness and lower cost compared with autologous chondrocyte implantation or osteochondral transplantation.¹⁸

Chondroplasty Versus Restorative Procedures

Chondroplasty is classified as a palliative treatment: it manages symptoms but doesn’t try to rebuild what’s been lost. The alternatives fall into two broad camps. Reparative techniques like microfracture poke small holes in the bone beneath a cartilage defect to encourage bleeding and the formation of fibrocartilage, a scar-tissue-like stand-in for the original hyaline cartilage. Restorative techniques like autologous chondrocyte implantation (ACI) and osteochondral grafting aim to rebuild something closer to the original cartilage surface.¹⁹

The expectation has been that restorative procedures, being more sophisticated and expensive, would produce better long-term results. The evidence is more nuanced. A randomized trial comparing ACI to alternative surgical management (which included microfracture and chondroplasty) in patients whose previous cartilage treatment had failed found that both groups improved substantially by one year, and there was no significant difference between them at five years. About half the patients in each group were still experiencing benefit at that point.²⁰

This doesn’t mean chondroplasty and ACI are interchangeable. They’re used for different situations: chondroplasty for smaller, partial-thickness lesions where the cartilage is fraying but not gone, and ACI for larger, full-thickness defects where the cartilage has worn through to bare bone. But it does suggest that more invasive and expensive doesn’t automatically mean better, and that the choice of procedure should be matched carefully to the specific defect and patient rather than defaulting to the most advanced option available.

Add-On Injections at the Time of Surgery

A growing area of interest is whether injecting biological therapies into the joint at the time of chondroplasty can improve outcomes. Platelet-rich plasma (PRP), made by concentrating growth factors from the patient’s own blood, is the most studied option. A randomized trial found that patients with moderate cartilage injuries who received a PRP injection during arthroscopic chondroplasty showed better and faster improvement on functional knee scores for up to two years compared with patients who had chondroplasty alone.²¹

However, the overall picture is less clear than any single positive trial suggests. A systematic review examining add-on injection therapies after cartilage repair procedures found that the evidence is mixed. Across studies using PRP, mesenchymal stem cells, and hyaluronic acid, roughly half showed a significant benefit and half did not, and the timing, dose, and frequency of injections varied widely.²² PRP is safe and relatively inexpensive, so some surgeons offer it as an adjunct, but it’s not yet standard of care.

How Imaging Tracks Cartilage After Surgery

Standard MRI can show the shape and thickness of cartilage after chondroplasty, but it doesn’t tell you much about the quality of what’s left. Newer MRI techniques are changing that. T2 mapping, for example, measures the water content and collagen structure of cartilage tissue, providing a way to detect early degeneration before the surface visibly breaks down.²³ Other advanced sequences can track sodium concentration or use contrast agents to assess how well cartilage is holding onto its structural molecules.²⁴

These tools aren’t used routinely after chondroplasty, at least not yet. They’re mostly found in research settings and specialized centers. But as cartilage imaging improves, it may eventually help surgeons decide when a treated area is deteriorating and when further intervention is needed, rather than waiting for symptoms to worsen. For now, most patients are followed with periodic standard MRI and clinical assessment of pain and function.

Recovery and What to Expect Afterward

Because chondroplasty doesn’t involve drilling into bone or implanting tissue, recovery is typically faster than for microfracture or ACI. Most patients are allowed to bear weight almost immediately, though some surgeons recommend partial weight-bearing for a week or two depending on the size and location of the treated area. Physical therapy usually begins within the first week and focuses on restoring range of motion, reducing swelling, and gradually strengthening the muscles around the joint.

Return to desk work or light daily activities often happens within one to two weeks. Return to sports takes longer. In the randomized trial comparing RF to mechanical chondroplasty, RF patients were back to activity at an average of about 17 days, while mechanical shaver patients took about 22 days.²⁵ For higher-demand sports, three to four months is more realistic, depending on what else was done during the surgery and the condition of the rest of the joint.

Young athletes with isolated cartilage injuries tend to do particularly well. A study of adolescents who underwent cartilage repair found that 96% returned to high-impact sports, and those who had the procedure within 12 months of the onset of symptoms were significantly more likely to return to their pre-injury level of competition. Waiting longer than a year before treatment appeared to reduce the chance of full athletic recovery.